Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insulin therapy].

P Brunetti1

  • 1Dipartimento di Medicina Interna, Università degli Studi, Perugia, Italy.

Minerva Endocrinologica
|August 2, 2001
PubMed
Summary
This summary is machine-generated.

Intensive insulin therapy and optimal metabolic control significantly prevent diabetes complications. New insulin analogues offer improved prandial and basal glucose control for better diabetes management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recreational use of GHB and prescribed drugs: the challenge in forensic and clinical toxicology.

La Clinica terapeutica·2021
Same author

Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017-2018: results from the first National screening campaign in community pharmacies.

Journal of public health (Oxford, England)·2021
Same author

Phytoextraction efficiency of Pteris vittata grown on a naturally As-rich soil and characterization of As-resistant rhizosphere bacteria.

Scientific reports·2021
Same author

Determination of benzodiazepines in pericardial fluid by gas chromatography-mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2018
Same author

Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients.

Journal of endocrinological investigation·2013
Same author

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2009
Same journal

Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.

Minerva endocrinologica·2021
Same journal

Effects of Mediterranean diet on semen parameters in healthy young adults: a randomized controlled trial.

Minerva endocrinologica·2021
Same journal

Next generation of strain specific probiotics in diabetes treatment: the case of Prevotella copri.

Minerva endocrinologica·2020
Same journal

New perspectives in neuroendocrine neoplasms research from tumor xenografts in zebrafish embryos.

Minerva endocrinologica·2020
Same journal

Codon bias analyses on thyroid carcinoma genes.

Minerva endocrinologica·2020
Same journal

The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus.

Minerva endocrinologica·2020
See all related articles

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology of Diabetes Therapeutics

Context:

  • Large clinical trials demonstrate microvascular and macrovascular complication prevention in type 1 and type 2 diabetes.
  • Optimal metabolic control is achievable through intensive insulin therapy or oral hypoglycemic agents.

Purpose:

  • To review the advancements in insulin therapy for diabetes management.
  • To highlight the benefits of new insulin analogues and formulations in achieving near-normal glycemic control.

Summary:

  • Intensive insulin therapy, including continuous subcutaneous insulin infusion or multiple daily injections with fast-acting analogues, effectively manages diabetes.
  • Protracted-acting insulin analogues like glargine and fatty acid derivatives offer improved pharmacokinetic profiles for sustained basal insulin levels.

Related Experiment Videos

  • Near-normalization of mean blood glucose, glycated hemoglobin, and postprandial glucose levels is crucial for preventing diabetic complications.

    • Impact:

    • Improved patient outcomes through enhanced prevention of long-term diabetic complications.
    • Provides clinicians with updated information on advanced insulin formulations for personalized diabetes treatment.
    • Facilitates better glycemic control and quality of life for individuals with diabetes.